Effects of interleukin-13 on cytokine secretion by human acute myelogenous leukemia blasts

Leukemia

Volumn 10, Issue 9, 1996, Pages 1497-1503

  Bruserud, O ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Acute myelogenous leukemia; Interleukin 13; Interleukin 4

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; CELL CULTURE; CELL PROLIFERATION; CELL SECRETION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL;

EID: 0029777411     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Minty A, Chalon P, Derocq J-M, Dumont X, Guillemot J-C, Kaghad M, Labit C, Laplatois P, Liauzun P, Miloux B, Minty C, Casselas P, Loison C, Lupker J, Shire D, Ferrara P, Caput D. Interleukin 13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362: 248-250.
2. McKenzie ANJ, Culpepper JA, de Waal Malefyt R, Briere F, Punnonen J, Aversa G, Sato A, Dang W, Cocks BC, Menon S, deVries JE, Banchereau J, Zurawski G. Interleukin 13, a T cell derived cytokine that regulates human monocyte and B cell function. Proc Natl Acad Sci USA 1993; 90: 3735-3739.
3. Punnonen J, Aversa G, Cocks BG, McKenzie ANJ, Menon S, Zurawski G, de Waal Malefyt R, de Vries JE. Interleukin 13 induces interleukin 4-dependent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993; 90: 3730-3734.
4. Aversa G, Punnonen J, Cocks BG, de val Malefyt R, Vega F Jr Zurawski SM, Zurawski G, de Vries JE. An interleukin 4 (IL4) mutant protein inhibits both IL4 or IL13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL4 and IL13 receptors. J Exp Med 1993; 178: 2213-2218.
5. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE, Mantovani A. Interleukin-1 type II receptors: a decoy target for IL1 that is regulated by IL4. Science 1993; 261: 472-475.
6. Colotta F, Re F, Muzio M, Polentarutti N, Minty A, Caput D, Ferrara P, Mantovani A. Interleukin 13 induces expression and release of interleukin 1 decoy receptor in human polymorphonuclear cells. J Biol Chem 1994; 269: 12403-12406.
7. Muzio M, Re F, Sironi M, Polentarutti N, Minty A, Caput D, Ferrara P, Mantovani A, Colotta F. Interleukin 13 induces the production of interleukin 1 receptor antagonist (IL1RA) and the expression of the mRNA for the intracellular (keratinocyte) form of IL1RA in human myelomonocytic cells. Blood 1994; 83: 1738-1743.
8. Jacobsen SE, Okkenhaug C, Veiby OP, Caput D, Ferrara P, Minty A. Interleukin 13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells. J Exp Med 1994; 180: 75-82.
9. Russel NH. Autocrine growth factors and leukemic hematopoiesis. Blood Rev 1992; 6: 149-156.
10. Fiedler W, Suciu E, Wittlief C, Ostertag W, Hossfeld DK. Mechanisms of growth factor expression in acute meyloid leukemia (AML). Leukemia 1990; 4: 459-461.
11. Wakamiya N, Stone R, Takeyama H, Spriggs D, Kufe D. Detection of tumour necrosis factor gene expression at a cellular level in human acute myeloid leukemias. Leukemia 1989; 3: 51-56.
12. Bradbury D, Zhu Y-M, Russel NH. Regulation of Bcl-2 expression and apoptosis in acute myeloblastic leukaemia cells by granulocyte-macrophage colony-stimulating factor. Leukemia 1994; 8: 786-791.
13. Sachs L, Lotem J. Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 1993; 82: 15-21.
14. Bullock G, Tang C, Tourkina E, Ibrado AM, Lutzky J, Huang Y, Mahoney ME, Bhalla K. Effects of combined treatment with interleukin 3 and interleukin 6 on 4-hydroxycyclophosphamide-induced programmed cell death or apoptosis in human myeloid leukemia cells. Exp Hematol 1993; 21: 1640-1647.
15. Gambercorti-Passerini C, Grignani F, Ariente F, Pandolfi PP, Pelicci PG, Parmiani G. Human CD4 T lymphocytes specifically recognize the fusion region of the hybride protein pml/RARα present in acute promyelocytic leukemia cells. Blood 1993; 81: 1369-1375.
16. Pawelec G. Immune surveillance in leukemia: rationale for immunotherapy. Hematol Rev 1994; 8: 123-147.
17. Bruserud Ø, Nesthus I, Bühring H-J, Pawelec G. Cytokine modulation of interleukin 1 and tumor necrosis factor a secretion from acute myelogenous leukemia blast cells in vitro. Leukemia Res 1995; 19: 15-22.
18. Jansen JH, Fibbe WE, Wienjens GH, Willemze R, Kluin-Nelemans JC. Inhibitory effect of interleukin 4 on the proliferation of acute myeloid leukemia cells with myelo-monocytic differentiation (AML-M4/M5); the role of interleukin 6. Leukemia 1993; 7: 643-645.
19. Bruserud Ø, Mentzoni L, Bühring H-J, Pawelec G. Effects of haematopoietic growth factors on interleukin 6 secretion by blast cells derived from acute myelogenous leukemia patients. Acta Haematol 1996 (in press).
20. Vallenga E, deWolf JTM, Beentjes JAM, Esselink MT, Smit JW, Halie MR. Divergent effects of interleukin 4 on the granulocyte colony-stimulating factor and IL3-supported myeloid colony formation from normal and leukemic bone marrow cells. Blood 1990; 75: 633-637.
21. Tony H-P, Shen B-J, Reusch P, Sebald W. Design of human interleukin 4 antagonists inhibiting interleukin 4-dependent and interleukin 13-dependent responses in T-cells and B-cells with high efficiency. Eur J Biochem 1995; 225: 659-665.
22. Matthews DJ, Clark PA, Herbert J, Morgan C, Armitage RJ, Kinnon C, Minty A, Grabstein KH, Caput D, Ferrara P, Callard R. Function of the interleukin 2 (IL2) receptor γ chain in biological responses of X-linked severe combined immunodeficient B cells to IL2, IL4, IL13 and IL15. Blood 1995; 85: 38-42.
23. Obiri NI, Debinski W, Leonards WJ, Puri RK. Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common y chain shared by receptors for interleukins 2, 4, 7, 9 and 15. J Biol Chem 1995; 270: 8797-8804.
24. Zurawski SM, Chomarat P, Djossou O, Bidaud C, McKenzie ANJ, Miossec P, Banchereau J, Zurawski G. The primary binding subunit of the human interleukin 4 receptor is also a component of the interleukin 13 receptor. J Biol Chem 1995; 270: 13869-13878.
25. Lemoli RM, Gulati SC, Strife A, Lambek C, Perez A, Clarkson BD. Proliferative response of acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL3, GM-CSF and G-CSF alone and in combination. Leukemia 1991; 5: 386-391.
26. Asano Y, Okamura S, Shibuya T, Harada M, Niho Y. Growth of clonogenic myeloblastic leukemia cells in the presence of human recombinant erythropoietin in addition to various human recombinant hematopoietic growth factors. Blood 1988; 72: 1682-1686.
27. Bruserud Ø. Effect of dipyridamole, theophyllamine and verapamil on spontaneous in vitro proliferation of myelogenous leukemia cells. Acta Oncol 1992; 31: 53-58.
28. Bruserud Ø, Pawelec G. Effects of dipyridamole and R-verapamil on in vitro proliferation of blast cells from patients with acute myelogenous leukaemia. Leukemia Res 1993; 17: 507-513.
29. Bruserud Ø, Gjertsen BT, Brustugun OT, Bassøe CF, Akselsen PE, Nesthus I, Bühring H-J, Pawelec G. Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia. Leukemia 1995; 9: 1910-1920.
30. Rambaldi A, Torcia M, Bettoni S, Vannier E, Barbui T, Shaw AR, Dinarello CA, Cozzolino F. Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin 1 receptor antagonist and lack of its expression by leukemic cells. Bood 1991; 78: 3248-3253.
31. Sissolak G, Hoffbrand AV, Mehta AB, Ganeshaguru K. Effects of Interferon γ on the expression of Interferon β, interleukin 6, granulocyte-macrophage colony-stimulating factor and tumor necrosis factor a in acute myeloid leukemia blasts. Leukemia 1992; 6: 1155-1160.
32. McGlave PB, Haake RJ, Bostrom BC, Brunning R, Hurd DD, Kim TH, Nesbit ME, Vercelotti GM, Weisdorf D, Woods WG, Ramsay NKC, Kersey JH. Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remission. Blood 1988; 72: 1512-1517.
33. Zurawski SM, Vega F, Huyghe B, Zurawski G. Receptors for interleukin 13 and interleukin 4 are complex and share a novel component that functions in signal transduction. EMBO J 1993; 12: 2663-2670.